Loading...

Esperion Therapeutics, Inc.

ESPR•NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$1.91
$0.00(0.00%)
U.S. Market opens in 7h 12m

Esperion Therapeutics, Inc. (ESPR) Stock Overview

Explore Esperion Therapeutics, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap397.1M
P/E Ratio-19.67
EPS (TTM)$-0.11
ROE0.06%
Fundamental Analysis

AI Price Forecasts

1 Month$2.34
3 Months$2.87
1 Year Target$3.91

ESPR Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Esperion Therapeutics, Inc. (ESPR) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 30.31, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $3.91.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -19.67 and a market capitalization of 397.1M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
-9.48%
1-Month Change
-27.10%
3-Month Change
-39.17%
6-Month Change
-29.52%
Year-to-Date (YTD) Change
-48.38%
1-Year Change
116.73%
3-Year Change
56.56%
5-Year Change
-93.34%
All-Time (Max) Change
-86.83%

Contact Information

https://www.esperion.com
734 887 3903
3891 Ranchero Drive, Ann Arbor, MI, 48108

Company Facts

304 Employees
IPO DateJun 26, 2013
CountryUS
Actively Trading

Frequently Asked Questions